Page 160 - Initial Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initial coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initial Coverage Today - Breaking & Trending Today

Pontem Corporation Announces Pricing of Upsized $600 Million Initial [...]

13 gennaio 2021 10:22
Fonte: Adnkronos
#economia-e-finanza
NEW YORK, Jan. 13, 2021 /PRNewswire/ Pontem Corporation (the Company ), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses and led by Chairman and Chief Executive Officer Hubertus Mühlhäuser and Lead Director Burak Alici, today announced the pricing of its initial public offering of 60,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange and trade under the ticker symbol PNTM.U beginning January 13, 2021. Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the New York Stoc ....

New York , United States , New York Stock Exchange , Burak Alici , York Stock Exchange , Credit Suisse Securities United States , Guggenheim Securities , Exchange Commission , Syndicate Prospectus Department , Prospectus Department , Prnewswire Pontem Corporation The Company , Chief Executive Officer Hubertus , Lead Director Burak Alici , Suisse Securities , Stephens Drive , Note Concerning Forward Looking Statements This , Risk Factors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் ஸ்டாக் பரிமாற்றம் , யார்க் ஸ்டாக் பரிமாற்றம் , கடன் ஸ்யூயி பத்திரங்கள் ஒன்றுபட்டது மாநிலங்களில் , கூகந்‌ஹைம் பத்திரங்கள் , பரிமாற்றம் தரகு , கூட்டமைப்பு ப்ரோஸ்பெக்டஸ் துறை , ப்ரோஸ்பெக்டஸ் துறை ,

SponsorsOne Inc.: SponsorsOne Reveals Its Initial Portfolio of Products for Distilled Spirits

SponsorsOne Inc.: SponsorsOne Reveals Its Initial Portfolio of Products for Distilled Spirits
Craft Distilled Spirits Market Is Poised To Grow $25.34 Billion Over The Next 4 Years With Whisky, Vodka And Gin Leading The Category
WATERLOO, ON / ACCESSWIRE / January 12, 2021 / SponsorsOne Inc., (CSE:SPO)(Frankfurt:5SO)(OTC PINK:SPONF), a company that utilizes its proprietary platform that combines digital marketing, wholesale and retail distribution, branding, and operational & funding capital, giving it a competitive first-mover advantage in rapidly selling proprietary brands focused in the Alcohol, Functional Beverage and Hemp Sectors, announced today its plan to launch a portfolio of premium distilled spirits which offered through retail distribution channels and direct to consumer. ....

United States , Aaron Miranda , Myles Bartholomew , Gary Bartholomew , Sponsorsone Inc , Company Listing Statement , Canadian Securities Exchange , Brands Inc , Beverage Consortium , Sponsorsone Media Inc , Over The Next , With Whisky , Vodka And Gin Leading The Category , Functional Beverage , Hemp Sectors , Premier Beverage Consortium , Rye Whiskey , Texas Juniper Berries , Meyer Lemons , Ruby Red , Doc Wylders , Common Shares , ஒன்றுபட்டது மாநிலங்களில் , ரோன் மிராண்டா , மைல்ஸ் பார்தலோமெவ் , கேரி பார்தலோமெவ் ,

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases

(1)
- Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging -
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of
18F-fluciclovine, a positron emission tomography (PET) imaging radiopharmaceutical being studied for potential use in detecting recurrent brain metastases. The REVELATE study is a Phase 3, multi-center, single-arm imaging study being conducted in the United States. Its purpose is to assess the diagnostic performance of
18F-fluciclovine PET in detecting recurrent brain metastases in patients previously treated with radiation therapy. The first patient dosed in the study was at Yale University, New Haven, Conn., under the auspices of Dr. Mariam Aboian, Assistant Professor of Radiology. ....

United States , United Kingdom , Samuelt Chao , Mariam Aboian , Peter Gardiner , Priscilla Harlan , Jonathan Allis , Kostenloser Wertpapierhandel , Clare Gidley , Mike Beyer , Yale University , Emory University , Drug Administration , Emory University Department Of Radiology , Sam Brown Inc , Bracco Group , Nuclear Medicine , Corporate Communications , European Union , Imaging Sciences , Department Of Radiation Oncology , Ge Healthcare , Earth Diagnostics , New Haven , Assistant Professor , Blue Earth Diagnostics ,

VectoIQ Acquisition Corp. II : Closes $345 Million Initial Public Offering

NEW YORK, Jan. 11, 2021 /PRNewswire/ VectoIQ Acquisition Corp. II today announced that it closed its initial public offering of 34,500,000 units, which included the full exercise of the. | January 17, 2021 ....

New York , United States , Lauren Odell Danielle Belopotosky , Stephen Girsky , Exchange Commission , Vectoiq Acquisition Corp , Prospectus Department , Broadridge Financial Services , Morgan Stanley Co , Nasdaq Capital Market , Morgan Stanley , Island Avenue , Chief Executive Officer , Risk Factors , Vecq Acqu Stock Exchange , Press Release , Of Vtiqu , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீபன் கிர்ஸ்கி , பரிமாற்றம் தரகு , ப்ரோஸ்பெக்டஸ் துறை , பிராட்ரிட்ஜ் நிதி சேவைகள் , மோர்கன் ஸ்டான்லி இணை , நாஸ்டாக் மூலதனம் சந்தை , மோர்கன் ஸ்டான்லி ,

SoftBank's SVF Investment Corp. Announces Pricing of $525 Million Initial Public Offering

LONDON, Jan. 7, 2021 /PRNewswire/ SVF Investment Corp. (the "Company") announced today the pricing of its initial public offering of 52,500,000 units at $10 per unit. The units will be listed ....

New York , United States , City Of , United Kingdom , Rowan Brown , Navneet Govil , Rajeev Misra , Guardant Health , Deutsche Bank Securities Inc , Exchange Commission On , Cantor Fitzgerald Co , Investment Corp , Exchange Commission , Syndicate Desk , Citigroup Global Markets Inc , Nasdaq Capital Market , Softbank Investment Advisers , Softbank Vision , Global Markets Inc , Cantor Fitzgerald , Equity Capital Markets , General Counsel , Risk Factors , Softbank Vision Funds , Ping An Good Doctor , Relay Therapeutics ,